Reviewed, UniProtKB/Swiss-Prot Q9ULD2 (MTUS1_HUMAN)

Names and origin

Protein names

Recommended name:
    Mitochondrial tumor suppressor 1
Alternative name(s):
    Angiotensin-II type 2 receptor-interacting protein

Gene names

Name:	MTUS1
Synonyms:	ATIP, GK1, KIAA1288, MTSG1

Organism

Homo sapiens (Human)

Taxonomic identifier

9606 [NCBI]

Taxonomic lineage

Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo

Protein attributes

Sequence length	1270 AA.
Sequence status	Complete.
Sequence processing	The displayed sequence is not processed.
Protein existence	Evidence at protein level.

General annotation (Comments)

Function	Cooperates with AGTR2 to inhibit ERK2 activation and cell proliferation. May be required for AGTR2 cell surface expression. Together with PTPN6, induces UBE2V2 expression upon angiotensin-II stimulation.
Subunit structure	Homodimer. Interacts with AGTR2. Interacts with PTPN6 By similarity.
Subcellular location	Mitochondrion. Golgi apparatusBy similarity. Cell membraneBy similarity. NucleusBy similarity. Note= In neurons, translocates into the nucleus after treatment with angiotensin-II By similarity.
Tissue specificity	Ubiquitously expressed (at protein level). Highly expressed in brain. Down-regulated in ovarian carcinoma, pancreas carcinoma, colon carcinoma and head and neck squamous cell carcinoma (HNSCC).
Involvement in disease	Defects in MTUS1 may be a cause of hepatocellular carcinoma (HCC) [MIM:114550].
Sequence similarities	Belongs to the MTUS1 family.
Sequence caution	The sequence AAH07328.1 differs from that shown. Reason: Miscellaneous discrepancy. Contaminating sequence. Potential poly-A sequence.

Ontologies

Keywords
Biological process	Cell cycle
Cellular component	Cell membrane Golgi apparatus Membrane Mitochondrion Nucleus
Coding sequence diversity	Alternative splicing Polymorphism
Disease	Disease mutation
Domain	Coiled coil
Molecular function	Anti-oncogene
PTM	Phosphoprotein
Gene Ontology (GO)
Biological process	negative regulation of cell cycle Inferred from electronic annotation. Source: UniProtKB-KW
Cellular component	Golgi apparatus Inferred from electronic annotation. Source: UniProtKB-KW mitochondrion Inferred from electronic annotation. Source: UniProtKB-KW nucleus Inferred from electronic annotation. Source: UniProtKB-KW plasma membrane Inferred from electronic annotation. Source: UniProtKB-KW
Complete GO annotation...

Alternative products

This entry describes 6 isoforms produced by alternative splicing. [Align] [Select]

Isoform 1 (identifier: Q9ULD2-1)

Also known as: ATIP3a;

This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry.

Notes: Major in most peripheral tissues.

Isoform 2 (identifier: Q9ULD2-2)

Also known as: ATIP3b;

The sequence of this isoform differs from the canonical sequence as follows:
     763-817: GKPTSLKTAQSSWVNLPRPLPKSKASLKSPALRRTGSTPSIASTHSELSTYSNNS → A

Notes: Abundant in most peripheral tissues.

Isoform 3 (identifier: Q9ULD2-3)

Also known as: ATIP1;

The sequence of this isoform differs from the canonical sequence as follows:
     1-834: Missing.
     835-874: QNGSSGSFYL...RKNLFTALNA → MLLSPKFSLS...FRRSTVVFHT

Notes: Major in brain, female reproductive tissues, thyroid and heart. Within brain, highly expressed in corpus callosum and pons.

Isoform 4 (identifier: Q9ULD2-4)

The sequence of this isoform differs from the canonical sequence as follows:
     1-928: Missing.
     929-946: GNTKFEALTVVIQHLLSE → MGCPSSKLCLYSPCAATR

Isoform 5 (identifier: Q9ULD2-5)

Also known as: ATIP2;

The sequence of this isoform differs from the canonical sequence as follows:
     763-770: GKPTSLKT → VLPKAAFS
     771-1270: Missing.

Notes: Expressed at very low levels in most tissues.

Isoform 6 (identifier: Q9ULD2-6)

Also known as: ATIP4;

The sequence of this isoform differs from the canonical sequence as follows:
     1-753: Missing.
     754-817: QRIRRVSSSG...SELSTYSNNS → MTVPGGFRSC...LLATFTGKKT

Notes: Brain-specific. Major in cerebellum and fetal brain.

Sequence annotation (Features)

	Feature key	Position(s)	Length	Description	Graphical view	Feature identifier
Molecule processing
	Chain	1 – 1270	1270	Mitochondrial tumor suppressor 1		PRO_0000305197
Regions
	Coiled coil	940 – 1231	292	Potential
Amino acid modifications
	Modified residue	381	1	Phosphoserine By similarity
	Modified residue	443	1	Phosphoserine
	Modified residue	620	1	Phosphoserine By similarity
	Modified residue	1245	1	Phosphoserine By similarity
	Modified residue	1255	1	Phosphoserine By similarity
	Modified residue	1264	1	Phosphoserine
	Modified residue	1266	1	Phosphoserine By similarity
	Modified residue	1268	1	Phosphoserine
Natural variations
	Alternative sequence	1 – 928	928	Missing in isoform 4.		VSP_028270
	Alternative sequence	1 – 834	834	Missing in isoform 3.		VSP_028271
	Alternative sequence	1 – 753	753	Missing in isoform 6.		VSP_028272
	Alternative sequence	754 – 817	64	QRIRR…YSNNS → MTVPGGFRSCTETDISSKIF INSTLTPPAGSERHYDATLL TLLVVGSYSLCIIPLLATFT GKKT in isoform 6.		VSP_028273
	Alternative sequence	763 – 817	55	GKPTS…YSNNS → A in isoform 2.		VSP_028274
	Alternative sequence	763 – 770	8	GKPTSLKT → VLPKAAFS in isoform 5.		VSP_028275
	Alternative sequence	771 – 1270	500	Missing in isoform 5.		VSP_028276
	Alternative sequence	835 – 874	40	QNGSS…TALNA → MLLSPKFSLSTIHIRLTAKG LLRNLRLPSGFRRSTVVFHT in isoform 3.		VSP_028277
	Alternative sequence	929 – 946	18	GNTKF…HLLSE → MGCPSSKLCLYSPCAATR in isoform 4.		VSP_028278
	Natural variant	75	1	Q → K in HCC.		VAR_035173
	Natural variant	148	1	C → R: dbSNP rs3739407.		VAR_035174
	Natural variant	186	1	T → S in HNSCC cell lines.		VAR_035175
	Natural variant	425	1	T → M		VAR_035176
	Natural variant	453	1	K → T: dbSNP rs17690844.		VAR_035177
	Natural variant	563	1	A → S in HCC.		VAR_035178
	Natural variant	575	1	H → R: dbSNP rs209569.		VAR_035179
	Natural variant	873	1	N → H in HCC.		VAR_035180
	Natural variant	911	1	K → T		VAR_035181
	Natural variant	1063	1	K → T: dbSNP rs17853231.		VAR_035182
	Natural variant	1105	1	E → Q		VAR_035183
	Natural variant	1201	1	Q → R in HCC.		VAR_035184
Experimental info
	Sequence conflict	266	1	C → G in CAB50791. Ref.5
	Sequence conflict	999	1	E → G in CAH56128. Ref.5
	Sequence conflict	1149	1	I → T in BAB14894. Ref.4

Sequences

	Sequence		Length	Mass (Da)
	Isoform 1 (ATIP3a) [UniParc]. Last modified October 2, 2007. Version 2. Checksum: 2EAE962F627BFFE3	FASTA	1,270	141,397
	10 20 30 40 50 60 MTDDNSDDKI EDELQTFFTS DKDGNTHAYN PKSPPTQNSS ASSVNWNSAN PDDMVVDYET 70 80 90 100 110 120 DPAVVTGENI SLSLQGVEVF GHEKSSSDFI SKQVLDMHKD SICQCPALVG TEKPKYLQHS 130 140 150 160 170 180 CHSLEAVEGQ SVEPSLPFVW KPNDNLNCAG YCDALELNQT FDMTVDKVNC TFISHHAIGK 190 200 210 220 230 240 SQSFHTAGSL PPTGRRSGST SSLSYSTWTS SHSDKTHARE TTYDRESFEN PQVTPSEAQD 250 260 270 280 290 300 MTYTAFSDVV MQSEVFVSDI GNQCACSSGK VTSEYTDGSQ QRLVGEKETQ ALTPVSDGME 310 320 330 340 350 360 VPNDSALQEF FCLSHDESNS EPHSQSSYRH KEMGQNLRET VSYCLIDDEC PLMVPAFDKS 370 380 390 400 410 420 EAQVLNPEHK VTETEDTQMV SKGKDLGTQN HTSELILSSP PGQKVGSSFG LTWDANDMVI 430 440 450 460 470 480 STDKTMCMST PVLEPTKVTF SVSPIEATEK CKKVEKGNRG LKNIPDSKEA PVNLCKPSLG 490 500 510 520 530 540 KSTIKTNTPI GCKVRKTEII SYPRPNFKNV KAKVMSRAVL QPKDAALSKV TPRPQQTSAS 550 560 570 580 590 600 SPSSVNSRQQ TVLSRTPRSD LNADKKAEIL INKTHKQQFN KLITSQAVHV TTHSKNASHR 610 620 630 640 650 660 VPRTTSAVKS NQEDVDKASS SNSACETGSV SALFQKIKGI LPVKMESAEC LEMTYVPNID 670 680 690 700 710 720 RISPEKKGEK ENGTSMEKQE LKQEIMNETF EYGSLFLGSA SKTTTTSGRN ISKPDSCGLR 730 740 750 760 770 780 QIAAPKAKVG PPVSCLRRNS DNRNPSADRA VSPQRIRRVS SSGKPTSLKT AQSSWVNLPR 790 800 810 820 830 840 PLPKSKASLK SPALRRTGST PSIASTHSEL STYSNNSGNA AVIKYEEKPP KPAFQNGSSG 850 860 870 880 890 900 SFYLKPLVSR AHVHLMKTPP KGPSRKNLFT ALNAVEKSRQ KNPRSLCIQP QTAPDALPPE 910 920 930 940 950 960 KTLELTQYKT KCENQSGFIL QLKQLLACGN TKFEALTVVI QHLLSEREEA LKQHKTLSQE 970 980 990 1000 1010 1020 LVNLRGELVT ASTTCEKLEK ARNELQTVYE AFVQQHQAEK TERENRLKEF YTREYEKLRD 1030 1040 1050 1060 1070 1080 TYIEEAEKYK MQLQEQFDNL NAAHETSKLE IEASHSEKLE LLKKAYEASL SEIKKGHEIE 1090 1100 1110 1120 1130 1140 KKSLEDLLSE KQESLEKQIN DLKSENDALN EKLKSEEQKR RAREKANLKN PQIMYLEQEL 1150 1160 1170 1180 1190 1200 ESLKAVLEIK NEKLHQQDIK LMKMEKLVDN NTALVDKLKR FQQENEELKA RMDKHMAISR 1210 1220 1230 1240 1250 1260 QLSTEQAVLQ ESLEKESKVN KRLSMENEEL LWKLHNGDLC SPKRSPTSSA IPLQSPRNSG 1270 SFPSPSISPR
	Isoform 2 (ATIP3b) [UniParc]. Checksum: ECC10DC1CA22BF72		1,216	135,661
	10 20 30 40 50 60 MTDDNSDDKI EDELQTFFTS DKDGNTHAYN PKSPPTQNSS ASSVNWNSAN PDDMVVDYET 70 80 90 100 110 120 DPAVVTGENI SLSLQGVEVF GHEKSSSDFI SKQVLDMHKD SICQCPALVG TEKPKYLQHS 130 140 150 160 170 180 CHSLEAVEGQ SVEPSLPFVW KPNDNLNCAG YCDALELNQT FDMTVDKVNC TFISHHAIGK 190 200 210 220 230 240 SQSFHTAGSL PPTGRRSGST SSLSYSTWTS SHSDKTHARE TTYDRESFEN PQVTPSEAQD 250 260 270 280 290 300 MTYTAFSDVV MQSEVFVSDI GNQCACSSGK VTSEYTDGSQ QRLVGEKETQ ALTPVSDGME 310 320 330 340 350 360 VPNDSALQEF FCLSHDESNS EPHSQSSYRH KEMGQNLRET VSYCLIDDEC PLMVPAFDKS 370 380 390 400 410 420 EAQVLNPEHK VTETEDTQMV SKGKDLGTQN HTSELILSSP PGQKVGSSFG LTWDANDMVI 430 440 450 460 470 480 STDKTMCMST PVLEPTKVTF SVSPIEATEK CKKVEKGNRG LKNIPDSKEA PVNLCKPSLG 490 500 510 520 530 540 KSTIKTNTPI GCKVRKTEII SYPRPNFKNV KAKVMSRAVL QPKDAALSKV TPRPQQTSAS 550 560 570 580 590 600 SPSSVNSRQQ TVLSRTPRSD LNADKKAEIL INKTHKQQFN KLITSQAVHV TTHSKNASHR 610 620 630 640 650 660 VPRTTSAVKS NQEDVDKASS SNSACETGSV SALFQKIKGI LPVKMESAEC LEMTYVPNID 670 680 690 700 710 720 RISPEKKGEK ENGTSMEKQE LKQEIMNETF EYGSLFLGSA SKTTTTSGRN ISKPDSCGLR 730 740 750 760 770 780 QIAAPKAKVG PPVSCLRRNS DNRNPSADRA VSPQRIRRVS SSAGNAAVIK YEEKPPKPAF 790 800 810 820 830 840 QNGSSGSFYL KPLVSRAHVH LMKTPPKGPS RKNLFTALNA VEKSRQKNPR SLCIQPQTAP 850 860 870 880 890 900 DALPPEKTLE LTQYKTKCEN QSGFILQLKQ LLACGNTKFE ALTVVIQHLL SEREEALKQH 910 920 930 940 950 960 KTLSQELVNL RGELVTASTT CEKLEKARNE LQTVYEAFVQ QHQAEKTERE NRLKEFYTRE 970 980 990 1000 1010 1020 YEKLRDTYIE EAEKYKMQLQ EQFDNLNAAH ETSKLEIEAS HSEKLELLKK AYEASLSEIK 1030 1040 1050 1060 1070 1080 KGHEIEKKSL EDLLSEKQES LEKQINDLKS ENDALNEKLK SEEQKRRARE KANLKNPQIM 1090 1100 1110 1120 1130 1140 YLEQELESLK AVLEIKNEKL HQQDIKLMKM EKLVDNNTAL VDKLKRFQQE NEELKARMDK 1150 1160 1170 1180 1190 1200 HMAISRQLST EQAVLQESLE KESKVNKRLS MENEELLWKL HNGDLCSPKR SPTSSAIPLQ 1210 SPRNSGSFPS PSISPR
	Isoform 3 (ATIP1) [UniParc]. Checksum: 196002F8C8D9A6DD		436	50,544
	10 20 30 40 50 60 MLLSPKFSLS TIHIRLTAKG LLRNLRLPSG FRRSTVVFHT VEKSRQKNPR SLCIQPQTAP 70 80 90 100 110 120 DALPPEKTLE LTQYKTKCEN QSGFILQLKQ LLACGNTKFE ALTVVIQHLL SEREEALKQH 130 140 150 160 170 180 KTLSQELVNL RGELVTASTT CEKLEKARNE LQTVYEAFVQ QHQAEKTERE NRLKEFYTRE 190 200 210 220 230 240 YEKLRDTYIE EAEKYKMQLQ EQFDNLNAAH ETSKLEIEAS HSEKLELLKK AYEASLSEIK 250 260 270 280 290 300 KGHEIEKKSL EDLLSEKQES LEKQINDLKS ENDALNEKLK SEEQKRRARE KANLKNPQIM 310 320 330 340 350 360 YLEQELESLK AVLEIKNEKL HQQDIKLMKM EKLVDNNTAL VDKLKRFQQE NEELKARMDK 370 380 390 400 410 420 HMAISRQLST EQAVLQESLE KESKVNKRLS MENEELLWKL HNGDLCSPKR SPTSSAIPLQ 430 SPRNSGSFPS PSISPR
	Isoform 4 [UniParc]. Checksum: 20C0995FFE927E24		342	39,775
	10 20 30 40 50 60 MGCPSSKLCL YSPCAATRRE EALKQHKTLS QELVNLRGEL VTASTTCEKL EKARNELQTV 70 80 90 100 110 120 YEAFVQQHQA EKTERENRLK EFYTREYEKL RDTYIEEAEK YKMQLQEQFD NLNAAHETSK 130 140 150 160 170 180 LEIEASHSEK LELLKKAYEA SLSEIKKGHE IEKKSLEDLL SEKQESLEKQ INDLKSENDA 190 200 210 220 230 240 LNEKLKSEEQ KRRAREKANL KNPQIMYLEQ ELESLKAVLE IKNEKLHQQD IKLMKMEKLV 250 260 270 280 290 300 DNNTALVDKL KRFQQENEEL KARMDKHMAI SRQLSTEQAV LQESLEKESK VNKRLSMENE 310 320 330 340 ELLWKLHNGD LCSPKRSPTS SAIPLQSPRN SGSFPSPSIS PR
	Isoform 5 (ATIP2) [UniParc]. Checksum: 46E8EA82686165D8		770	84,252
	10 20 30 40 50 60 MTDDNSDDKI EDELQTFFTS DKDGNTHAYN PKSPPTQNSS ASSVNWNSAN PDDMVVDYET 70 80 90 100 110 120 DPAVVTGENI SLSLQGVEVF GHEKSSSDFI SKQVLDMHKD SICQCPALVG TEKPKYLQHS 130 140 150 160 170 180 CHSLEAVEGQ SVEPSLPFVW KPNDNLNCAG YCDALELNQT FDMTVDKVNC TFISHHAIGK 190 200 210 220 230 240 SQSFHTAGSL PPTGRRSGST SSLSYSTWTS SHSDKTHARE TTYDRESFEN PQVTPSEAQD 250 260 270 280 290 300 MTYTAFSDVV MQSEVFVSDI GNQCACSSGK VTSEYTDGSQ QRLVGEKETQ ALTPVSDGME 310 320 330 340 350 360 VPNDSALQEF FCLSHDESNS EPHSQSSYRH KEMGQNLRET VSYCLIDDEC PLMVPAFDKS 370 380 390 400 410 420 EAQVLNPEHK VTETEDTQMV SKGKDLGTQN HTSELILSSP PGQKVGSSFG LTWDANDMVI 430 440 450 460 470 480 STDKTMCMST PVLEPTKVTF SVSPIEATEK CKKVEKGNRG LKNIPDSKEA PVNLCKPSLG 490 500 510 520 530 540 KSTIKTNTPI GCKVRKTEII SYPRPNFKNV KAKVMSRAVL QPKDAALSKV TPRPQQTSAS 550 560 570 580 590 600 SPSSVNSRQQ TVLSRTPRSD LNADKKAEIL INKTHKQQFN KLITSQAVHV TTHSKNASHR 610 620 630 640 650 660 VPRTTSAVKS NQEDVDKASS SNSACETGSV SALFQKIKGI LPVKMESAEC LEMTYVPNID 670 680 690 700 710 720 RISPEKKGEK ENGTSMEKQE LKQEIMNETF EYGSLFLGSA SKTTTTSGRN ISKPDSCGLR 730 740 750 760 770 QIAAPKAKVG PPVSCLRRNS DNRNPSADRA VSPQRIRRVS SSVLPKAAFS
	Isoform 6 (ATIP4) [UniParc]. Checksum: 43755CC4B064F012		517	58,988
	10 20 30 40 50 60 MTVPGGFRSC TETDISSKIF INSTLTPPAG SERHYDATLL TLLVVGSYSL CIIPLLATFT 70 80 90 100 110 120 GKKTGNAAVI KYEEKPPKPA FQNGSSGSFY LKPLVSRAHV HLMKTPPKGP SRKNLFTALN 130 140 150 160 170 180 AVEKSRQKNP RSLCIQPQTA PDALPPEKTL ELTQYKTKCE NQSGFILQLK QLLACGNTKF 190 200 210 220 230 240 EALTVVIQHL LSEREEALKQ HKTLSQELVN LRGELVTAST TCEKLEKARN ELQTVYEAFV 250 260 270 280 290 300 QQHQAEKTER ENRLKEFYTR EYEKLRDTYI EEAEKYKMQL QEQFDNLNAA HETSKLEIEA 310 320 330 340 350 360 SHSEKLELLK KAYEASLSEI KKGHEIEKKS LEDLLSEKQE SLEKQINDLK SENDALNEKL 370 380 390 400 410 420 KSEEQKRRAR EKANLKNPQI MYLEQELESL KAVLEIKNEK LHQQDIKLMK MEKLVDNNTA 430 440 450 460 470 480 LVDKLKRFQQ ENEELKARMD KHMAISRQLS TEQAVLQESL EKESKVNKRL SMENEELLWK 490 500 510 LHNGDLCSPK RSPTSSAIPL QSPRNSGSFP SPSISPR

References

	« Hide 'large scale' referencesShow 'large scale' references »
[1]	"Molecular cloning and characterization of two novel genes on chromosome 8p21.3." Kinjo T., Isomura M., Iwamasa T., Nakamura Y. J. Hum. Genet. 45:12-17(2000) [PubMed: 10697957] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY, SUBCELLULAR LOCATION.
[2]	"Identification of a new tumor suppressor gene located at chromosome 8p21.3-22." Seibold S., Rudroff C., Weber M., Galle J., Wanner C., Marx M. FASEB J. 17:1180-1182(2003) [PubMed: 12692079] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), FUNCTION, TISSUE SPECIFICITY, SUBCELLULAR LOCATION.
[3]	"Trans-inactivation of receptor tyrosine kinases by novel angiotensin II AT2 receptor-interacting protein, ATIP." Nouet S., Amzallag N., Li J.-M., Louis S., Seitz I., Cui T.-X., Alleaume A.-M., Di Benedetto M., Boden C., Masson M., Strosberg A.D., Horiuchi M., Couraud P.-O., Nahmias C. J. Biol. Chem. 279:28989-28997(2004) [PubMed: 15123706] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), ALTERNATIVE SPLICING (ISOFORMS 1; 5 AND 6), SUBUNIT, TISSUE SPECIFICITY. Tissue: Lung.
[4]	"Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. , Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K., Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B., Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S. Nat. Genet. 36:40-45(2004) [PubMed: 14702039] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 6), NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 875-1270 (ISOFORM 1). Tissue: Fetal brain and Placenta.
[5]	The German cDNA consortium Submitted (SEP-2004) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4), NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 266-1270 (ISOFORM 5). Tissue: Salivary gland and Uterus.
[6]	"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3), NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 681-1270 (ISOFORM 1), VARIANT THR-1063. Tissue: Ovary and Skin.
[7]	"Differential expression in normal trophoblast and gestational tumors." Abadie P.A., Genti-Raimondi S. Submitted (AUG-2003) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 1-891 (ISOFORM 2), VARIANTS ARG-148 AND ARG-575.
[8]	"Prediction of the coding sequences of unidentified human genes. XV. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro." Nagase T., Ishikawa K., Kikuno R., Hirosawa M., Nomura N., Ohara O. DNA Res. 6:337-345(1999) [PubMed: 10574462] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 26-1270 (ISOFORM 1). Tissue: Brain.
[9]	"Five genes from chromosomal band 8p22 are significantly down-regulated in ovarian carcinoma: N33 and EFA6R have a potential impact on overall survival." Pils D., Horak P., Gleiss A., Sax C., Fabjani G., Moebus V.J., Zielinski C., Reinthaller A., Zeillinger R., Krainer M. Cancer 104:2417-2429(2005) [PubMed: 16270321] [Abstract] Cited for: TISSUE SPECIFICITY.
[10]	"Global, in vivo, and site-specific phosphorylation dynamics in signaling networks." Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C.,